- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/36 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class A61K 38/36
Total number of patents in this class: 1068
10-year publication summary
|
79
|
89
|
82
|
98
|
83
|
80
|
69
|
55
|
67
|
11
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
37 |
| Bioverativ Therapeutics Inc. | 220 |
26 |
| CSL Behring GmbH | 350 |
25 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 306 |
25 |
| The Children's Hospital of Philadelphia | 716 |
20 |
| Baxter International Inc. | 2425 |
16 |
| Baxter Healthcare S.A. | 1810 |
16 |
| RegenLab USA LLC | 65 |
15 |
| Ethicon, Inc. | 1310 |
14 |
| Omrix Biopharmaceuticals Ltd. | 159 |
14 |
| Quiapeg Pharmaceuticals AB | 46 |
12 |
| Fibrex Medical Research & Development GmbH | 12 |
11 |
| The Regents of the University of California | 18943 |
10 |
| Asahi Kasei Pharma Corporation | 144 |
10 |
| Octapharma AG | 201 |
10 |
| The Board of Trustees of the University of Illinois | 2623 |
9 |
| Mayo Foundation for Medical Education and Research | 2981 |
8 |
| Novo Nordisk Health Care AG | 342 |
8 |
| St. Teresa Medical, Inc. | 29 |
8 |
| Combangio, Inc. | 22 |
8 |
| Other owners | 766 |